Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUANTUM Trip Trial: Psilocybin for Alcohol Use Disorder
NCT05416229Phase 2Completed
- Start
- Sep 2023
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in alcohol use disorder (AUD). Started Sep 2023; status: completed.
02
Drugs
psilocybin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05416229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05416229.